CTMX
CytomX Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.35
+7.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.70x
- Price / sales
- 27.98x
- Price / cash flow
- -6.21x
Enterprise value
- Enterprise value
- $187.5M
- EV / sales
- 10.24x
- EV / EBITDA
- -2.39x
- EV / EBIT
- -2.15x
- Market cap
- $512.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026